[Clinical study of early pregnancy termination by administration of DL-15-methyl prostaglandin F2 alpha combined with tamoxifen or norethisterone].
Zhang
J H
JH
Yan
B Y
BY
Lu
X Y
XY
D000019:Abortifacient Agents; D000028:Abortion, Induced; D001208:Asia; D001695:Biology; D002681:China; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003906:Developing Countries; D004703:Endocrine System; D005193:Family Planning Services; D005202:Asia, Eastern; D009640:Norethindrone; D010827:Physiology; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011453:Prostaglandins; D011465:Prostaglandins, Synthetic; D012098:Reproduction
D000019:Abortifacient Agents; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D011453:Prostaglandins; D011465:Prostaglandins, Synthetic; D009640:Norethindrone
Abortifacient Agents; Abortion, Drug Induced; Abortion, Induced; Asia; Biology; China; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Developing Countries; Eastern Asia; Endocrine System; Family Planning; Fertility Control, Postconception; Norethindrone; Physiology; Pregnancy; Pregnancy, First Trimester; Prostaglandins; Prostaglandins, Synthetic; Reproduction; Research Report